US NeuroSurgical Holdings Inc
Elite Health Systems Inc., through its subsidiaries, develops a business to provide Medicare Advantage plans and related services in California and Nevada. The company was formerly known as U.S. NeuroSurgical Holdings, Inc. and changed its name to Elite Health Systems Inc. in September 2024. Elite Health Systems Inc. was founded in 1993 and is headquartered in Ontario, California.
US NeuroSurgical Holdings Inc (USNU) - Total Assets
Latest total assets as of June 2025: $3.98 Million USD
Based on the latest financial reports, US NeuroSurgical Holdings Inc (USNU) holds total assets worth $3.98 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
US NeuroSurgical Holdings Inc - Total Assets Trend (1997–2024)
This chart illustrates how US NeuroSurgical Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
US NeuroSurgical Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
US NeuroSurgical Holdings Inc's total assets of $3.98 Million consist of 98.3% current assets and 1.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 93.4% |
| Accounts Receivable | $189.00K | 4.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1997–2024)
This chart illustrates how US NeuroSurgical Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: US NeuroSurgical Holdings Inc's current assets represent 98.3% of total assets in 2024, an increase from 4.2% in 1997.
- Cash Position: Cash and equivalents constituted 93.4% of total assets in 2024, up from 0.9% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1997.
- Asset Diversification: The largest asset category is accounts receivable at 4.4% of total assets.
US NeuroSurgical Holdings Inc Competitors by Total Assets
Key competitors of US NeuroSurgical Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
US NeuroSurgical Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - US NeuroSurgical Holdings Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - US NeuroSurgical Holdings Inc is currently not profitable relative to its asset base.
US NeuroSurgical Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 18.93 | 2.30 | 3.42 |
| Quick Ratio | 18.93 | 2.30 | 3.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.00 Million | $ 1.26 Million | $ 1.91 Million |
US NeuroSurgical Holdings Inc - Advanced Valuation Insights
This section examines the relationship between US NeuroSurgical Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.99 |
| Latest Market Cap to Assets Ratio | 2.66 |
| Asset Growth Rate (YoY) | 227.1% |
| Total Assets | $4.32 Million |
| Market Capitalization | $11.51 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values US NeuroSurgical Holdings Inc's assets at a significant premium ( 2.66x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: US NeuroSurgical Holdings Inc's assets grew by 227.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for US NeuroSurgical Holdings Inc (1997–2024)
The table below shows the annual total assets of US NeuroSurgical Holdings Inc from 1997 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.32 Million | +227.10% |
| 2023-12-31 | $1.32 Million | -24.38% |
| 2022-12-31 | $1.75 Million | -52.63% |
| 2021-12-31 | $3.69 Million | -11.62% |
| 2020-12-31 | $4.17 Million | -16.49% |
| 2019-12-31 | $5.00 Million | -19.47% |
| 2018-12-31 | $6.21 Million | -21.60% |
| 2017-12-31 | $7.92 Million | -3.99% |
| 2016-12-31 | $8.24 Million | +11.62% |
| 2015-12-31 | $7.39 Million | -0.87% |
| 2014-12-31 | $7.45 Million | +258.22% |
| 2013-12-31 | $2.08 Million | -60.70% |
| 2012-12-31 | $5.29 Million | +27.08% |
| 2011-12-31 | $4.17 Million | -13.45% |
| 2010-12-31 | $4.81 Million | -4.68% |
| 2009-12-31 | $5.05 Million | +129.77% |
| 2008-12-31 | $2.20 Million | -16.81% |
| 2007-12-31 | $2.64 Million | -24.46% |
| 2006-12-31 | $3.50 Million | -25.03% |
| 2005-12-31 | $4.66 Million | +11.00% |
| 2004-12-31 | $4.20 Million | +33.37% |
| 2003-12-31 | $3.15 Million | +6.31% |
| 2002-12-31 | $2.96 Million | -21.92% |
| 2001-12-31 | $3.79 Million | -21.85% |
| 2000-12-31 | $4.86 Million | -8.08% |
| 1999-12-31 | $5.28 Million | -9.09% |
| 1998-12-31 | $5.81 Million | -15.04% |
| 1997-12-31 | $6.84 Million | -- |